3.72 USD
+0.09 (+2.48%)
3.74 USD
+0.02 (+0.54%)
UROY gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 209 industry peers in the Oil, Gas & Consumable Fuels industry. No worries on liquidiy or solvency for UROY as it has an excellent financial health rating, but there are worries on the profitability. UROY has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year UROY has reported negative net income.
UROY had a positive operating cash flow in the past year.
In the past 5 years UROY reported 4 times negative net income.
In the past 5 years UROY always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of UROY (-0.66%) is worse than 69.52% of its industry peers.
UROY has a Return On Equity of -0.66%. This is in the lower half of the industry: UROY underperforms 67.62% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.12%, UROY is doing worse than 75.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.66% | ||
| ROE | -0.66% | ||
| ROIC | 0.12% |
ROA(3y)-0.51%
ROA(5y)-1.15%
ROE(3y)-0.57%
ROE(5y)-1.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Operating Margin value of 0.94%, UROY is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
With a Gross Margin value of 18.11%, UROY is not doing good in the industry: 66.19% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.94% | ||
| PM (TTM) | N/A | ||
| GM | 18.11% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so UROY is destroying value.
UROY has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, UROY has more shares outstanding
UROY has a worse debt/assets ratio than last year.
2.2 Solvency
UROY has an Altman-Z score of 327.62. This indicates that UROY is financially healthy and has little risk of bankruptcy at the moment.
UROY has a Altman-Z score of 327.62. This is amongst the best in the industry. UROY outperforms 100.00% of its industry peers.
UROY has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.01, UROY belongs to the best of the industry, outperforming 91.90% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that UROY is not too dependend on debt financing.
UROY has a better Debt to Equity ratio (0.00) than 83.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | 327.62 |
ROIC/WACC0.02
WACC7.84%
2.3 Liquidity
UROY has a Current Ratio of 201.73. This indicates that UROY is financially healthy and has no problem in meeting its short term obligations.
UROY's Current ratio of 201.73 is amongst the best of the industry. UROY outperforms 100.00% of its industry peers.
UROY has a Quick Ratio of 41.86. This indicates that UROY is financially healthy and has no problem in meeting its short term obligations.
UROY's Quick ratio of 41.86 is amongst the best of the industry. UROY outperforms 99.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 201.73 | ||
| Quick Ratio | 41.86 |
3. Growth
3.1 Past
UROY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -117.00%.
Looking at the last year, UROY shows a quite strong growth in Revenue. The Revenue has grown by 14.29% in the last year.
EPS 1Y (TTM)-117%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%157%
Revenue 1Y (TTM)14.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
UROY is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -148.34% yearly.
Based on estimates for the next years, UROY will show a very negative growth in Revenue. The Revenue will decrease by -37.41% on average per year.
EPS Next Y400.3%
EPS Next 2Y-224.2%
EPS Next 3Y-148.34%
EPS Next 5YN/A
Revenue Next Year174.39%
Revenue Next 2Y-75.5%
Revenue Next 3Y-37.41%
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
UROY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year UROY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UROY is valued a bit more expensive than the industry average as 75.71% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of UROY is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 49.64 | ||
| EV/EBITDA | 1014.95 |
4.3 Compensation for Growth
UROY's earnings are expected to decrease with -148.34% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-224.2%
EPS Next 3Y-148.34%
5. Dividend
5.1 Amount
No dividends for UROY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.72
+0.09 (+2.48%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners28.31%
Inst Owner Change1.25%
Ins Owners2.18%
Ins Owner ChangeN/A
Market Cap514.66M
Revenue(TTM)48.81M
Net Income(TTM)-1.97M
Analysts75
Price Target3.78 (1.61%)
Short Float %9.29%
Short Ratio2.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.39%
PT rev (3m)10.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-50%
EPS NY rev (3m)-75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 14.78 | ||
| P/FCF | 49.64 | ||
| P/OCF | 33.12 | ||
| P/B | 2.43 | ||
| P/tB | 2.43 | ||
| EV/EBITDA | 1014.95 |
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)0.07
FCFY2.01%
OCF(TTM)0.11
OCFY3.02%
SpS0.25
BVpS1.53
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.66% | ||
| ROE | -0.66% | ||
| ROCE | 0.16% | ||
| ROIC | 0.12% | ||
| ROICexc | 0.15% | ||
| ROICexgc | 0.15% | ||
| OM | 0.94% | ||
| PM (TTM) | N/A | ||
| GM | 18.11% | ||
| FCFM | 29.77% |
ROA(3y)-0.51%
ROA(5y)-1.15%
ROE(3y)-0.57%
ROE(5y)-1.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 4472.22% | ||
| Cap/Sales | 14.84% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 3495.51% | ||
| Profit Quality | N/A | ||
| Current Ratio | 201.73 | ||
| Quick Ratio | 41.86 | ||
| Altman-Z | 327.62 |
F-Score5
WACC7.84%
ROIC/WACC0.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%157%
EPS Next Y400.3%
EPS Next 2Y-224.2%
EPS Next 3Y-148.34%
EPS Next 5YN/A
Revenue 1Y (TTM)14.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year174.39%
Revenue Next 2Y-75.5%
Revenue Next 3Y-37.41%
Revenue Next 5YN/A
EBIT growth 1Y-92.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year142.68%
EBIT Next 3Y3.56%
EBIT Next 5YN/A
FCF growth 1Y345.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y468.48%
OCF growth 3YN/A
OCF growth 5YN/A
URANIUM ROYALTY CORP / UROY FAQ
What is the fundamental rating for UROY stock?
ChartMill assigns a fundamental rating of 3 / 10 to UROY.
What is the valuation status of URANIUM ROYALTY CORP (UROY) stock?
ChartMill assigns a valuation rating of 1 / 10 to URANIUM ROYALTY CORP (UROY). This can be considered as Overvalued.
How profitable is URANIUM ROYALTY CORP (UROY) stock?
URANIUM ROYALTY CORP (UROY) has a profitability rating of 0 / 10.
How financially healthy is URANIUM ROYALTY CORP?
The financial health rating of URANIUM ROYALTY CORP (UROY) is 8 / 10.
Can you provide the expected EPS growth for UROY stock?
The Earnings per Share (EPS) of URANIUM ROYALTY CORP (UROY) is expected to grow by 400.3% in the next year.